Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-01-01 @ 7:24 AM
Study NCT ID:
NCT04052204
Status:
TERMINATED
Last Update Posted:
2021-10-14
First Post:
2019-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-02
First Submit QC Date:
None
Study First Post Date:
2019-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-02
Results First Submit QC Date:
None
Results First Post Date:
2021-10-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-17
Last Update Post Date:
2021-10-14
Last Update Post Date Type:
ACTUAL